CIK 0001620463 · Non-accelerated filer<br>Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 453368487
- Phone
- (425) 620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 85 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units | −5,856 | 0 | ||
| 2026-03-03 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise | +7,418 | 17,607 | ||
| 2026-03-03 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −7,418 | 0 | ||
| 2026-03-03 | Litton Mark James PRESIDENT and CEO | Option exercise | +22,254 | 63,082 | ||
| 2026-03-03 | Litton Mark James PRESIDENT and CEO | Option exercise · Restricted Stock Units | −22,254 | 0 | ||
| 2026-01-02 | Renninger Robert Chief Financial Officer | Sale | −297 | $6.88 | $2K | 12,857 |
| 2026-01-02 | Worthington Mark General Counsel and CCO | Sale | −876 | $6.88 | $6K | 13,978 |
| 2026-01-02 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | −876 | $6.88 | $6K | 20,681 |
| 2026-01-02 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | −1,644 | $6.88 | $11K | 10,189 |
| 2026-01-02 | Litton Mark James President and CEO | Sale | −2,586 | $6.88 | $18K | 40,828 |
| 2025-12-31 | Renninger Robert Chief Financial Officer | Option exercise | +1,236 | 13,154 | ||
| 2025-12-31 | Renninger Robert Chief Financial Officer | Option exercise · Restricted Stock Units | −1,236 | 0 | ||
| 2025-12-31 | Worthington Mark General Counsel and CCO | Option exercise | +3,667 | 14,854 | ||
| 2025-12-31 | Worthington Mark General Counsel and CCO | Option exercise · Restricted Stock Units | −3,667 | 0 | ||
| 2025-12-31 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise | +3,667 | 21,557 | ||
| 2025-12-31 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units | −3,667 | 0 | ||
| 2025-12-31 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise | +4,667 | 11,833 | ||
| 2025-12-31 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −4,667 | 0 | ||
| 2025-12-31 | Litton Mark James President and CEO | Option exercise | +10,834 | 43,414 | ||
| 2025-12-31 | Litton Mark James President and CEO | Option exercise · Restricted Stock Units | −10,834 | 0 |
Page 3 of 10 · 187 trades